Commit Biologics Secures €5.5 Million Investment for Innovative Cancer Therapy Development Commit Biologics announces a €5.5 million investment from Korys, enhancing their groundbreaking BiCE™ platform for cancer treatment with ambitious goals.

Commit Biologics Secures €5.5 Million Investment for Innovative Cancer Therapy Development #Denmark #Aarhus #Commit_Biologics #BiCE #Korys